Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
eyesucom
- Development stage
- Unknown
- Lead developer
- Shanghai Haohai Biological Technology
- Modality
- Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Administration
- Ophthalmic
01
Overview
Eyesucom is a self-developed lubricant eye drop formulated with exclusive patented ingredients, including medical chitosan and sodium hyaluronate. It is manufactured using an aseptic packaging method without preservatives. The product provides natural antibacterial, moisturizing, and lubricating effects, promotes the repair of corneal epithelial damage, reduces staining, and comprehensively protects the ocular surface health—particularly for wearers of orthokeratology lenses. Its mechanism relies on the bioactive properties of chitosan (noted for its antimicrobial and wound-healing support) and sodium hyaluronate (a well-established ocular lubricant that enhances tear film stability). Eyesucom is positioned as a non-prescription ophthalmic solution for eye surface protection and comfort[6][10][8].
- Brand names
- Eyesucom
- Other names
- Eyesucom
Beyond the preview
Go deeper on eyesucom.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on eyesucom.